SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-23-000012
Filing Date
2023-04-14
Accepted
2023-04-14 16:25:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2732
  Complete submission text file 0001972362-23-000012.txt   4229
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Subject) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39138 | Film No.: 23821485
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O QIMING U.S. HEALTHCARE 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004
Business Address
French Anna Louise (Reporting) CIK: 0001871871 (see all company filings)

Type: 144